Bismuth-based susceptibility-guided treatment

DRUG2 trials

Sponsors

National Cheng-Kung University Hospital

Conditions

Drug Resistance, MultipleHelicobacter PyloriVirulence Factor

Phase 4

14-day Susceptibility-guided Bismuth Quadruple Therapy for Multiple Drug Resistant H. Pylori Infection

CompletedNCT06687499

National Cheng-Kung University HospitalDrug Resistance, Multiple, Helicobacter Pylori

Start: 2022-08-22End: 2024-01-26Updated: 2024-11-13

Susceptibility-guided Bismuth Quadruple Therapy for Multiple-resistant Helicobacter Pylori Strains

CompletedNCT06687473

National Cheng-Kung University HospitalDrug Resistance, Multiple, Helicobacter Pylori, Virulence Factor

Start: 2022-01-01End: 2023-03-31Updated: 2024-11-13